Literature DB >> 22625207

Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo.

Bashir M Mohamed1, Navin K Verma, Anthony M Davies, Aoife McGowan, Kieran Crosbie-Staunton, Adriele Prina-Mello, Dermot Kelleher, Catherine H Botting, Corey P Causey, Paul R Thompson, Ger Jm Pruijn, Elena R Kisin, Alexey V Tkach, Anna A Shvedova, Yuri Volkov.   

Abstract

AIM: Rapidly expanding manufacture and use of nanomaterials emphasize the requirements for thorough assessment of health outcomes associated with novel applications. Post-translational protein modifications catalyzed by Ca(2+)-dependent peptidylargininedeiminases have been shown to trigger immune responses including autoantibody generation, a hallmark of immune complexes deposition in rheumatoid arthritis. Therefore, the aim of the study was to assess if nanoparticles are able to promote protein citrullination. MATERIALS &
METHODS: Human A549 and THP-1 cells were exposed to silicon dioxide, carbon black or single-walled carbon nanotubes. C57BL/6 mice were exposed to respirable single-walled carbon nanotubes. Protein citrullination, peptidylargininedeiminases activity and target proteins were evaluated.
RESULTS: The studied nanoparticles induced protein citrullination both in cultured human cells and mouse lung tissues. Citrullination occurred via the peptidylargininedeiminase-dependent mechanism. Cytokeratines 7, 8, 18 and plectins were identified as intracellular citrullination targets.
CONCLUSION: Nanoparticle exposure facilitated post-translational citrullination of proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22625207      PMCID: PMC3465773          DOI: 10.2217/nnm.11.177

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  71 in total

Review 1.  'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments.

Authors:  Pierre A Coulombe; M Bishr Omary
Journal:  Curr Opin Cell Biol       Date:  2002-02       Impact factor: 8.382

Review 2.  Immunity to citrullinated proteins in rheumatoid arthritis.

Authors:  Lars Klareskog; Johan Rönnelid; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Health effects of inhaled engineered and incidental nanoparticles.

Authors:  Amy K Madl; Kent E Pinkerton
Journal:  Crit Rev Toxicol       Date:  2009       Impact factor: 5.635

4.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

5.  Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes.

Authors:  Jiumei Chen; Jessica A Hessler; Krishna Putchakayala; Brian K Panama; Damian P Khan; Seungpyo Hong; Douglas G Mullen; Stassi C Dimaggio; Abhigyan Som; Gregory N Tew; Anatoli N Lopatin; James R Baker; Mark M Banaszak Holl; Bradford G Orr
Journal:  J Phys Chem B       Date:  2009-08-13       Impact factor: 2.991

6.  Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  P Stolt; H Källberg; I Lundberg; B Sjögren; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2004-08-19       Impact factor: 19.103

7.  Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity.

Authors:  Anna A Shvedova; James P Fabisiak; Elena R Kisin; Ashley R Murray; Jenny R Roberts; Yulia Y Tyurina; James M Antonini; Wei Hong Feng; Choudari Kommineni; Jeffrey Reynolds; Aaron Barchowsky; Vince Castranova; Valerian E Kagan
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

8.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

9.  Mucin secretion induced by titanium dioxide nanoparticles.

Authors:  Eric Y T Chen; Maria Garnica; Yung-Chen Wang; Chi-Shuo Chen; Wei-Chun Chin
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

10.  Inhaled carbon nanotubes reach the subpleural tissue in mice.

Authors:  Jessica P Ryman-Rasmussen; Mark F Cesta; Arnold R Brody; Jeanette K Shipley-Phillips; Jeffrey I Everitt; Earl W Tewksbury; Owen R Moss; Brian A Wong; Darol E Dodd; Melvin E Andersen; James C Bonner
Journal:  Nat Nanotechnol       Date:  2009-10-25       Impact factor: 39.213

View more
  29 in total

Review 1.  Intracellular signal modulation by nanomaterials.

Authors:  Salik Hussain; Stavros Garantziotis; Fernando Rodrigues-Lima; Jean-Marie Dupret; Armelle Baeza-Squiban; Sonja Boland
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

2.  Macrophage silica nanoparticle response is phenotypically dependent.

Authors:  Heather L Herd; Kristopher T Bartlett; Joshua A Gustafson; Lawrence D McGill; Hamidreza Ghandehari
Journal:  Biomaterials       Date:  2015-03-23       Impact factor: 12.479

Review 3.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 4.  Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis.

Authors:  Anca I Catrina; A Jimmy Ytterberg; Gudrun Reynisdottir; Vivianne Malmström; Lars Klareskog
Journal:  Nat Rev Rheumatol       Date:  2014-07-29       Impact factor: 20.543

5.  Citrullinated vimentin mediates development and progression of lung fibrosis.

Authors:  Fu Jun Li; Ranu Surolia; Huashi Li; Zheng Wang; Gang Liu; Tejaswini Kulkarni; Adriana V F Massicano; James A Mobley; Santanu Mondal; Joao A de Andrade; Scott A Coonrod; Paul R Thompson; Keith Wille; Suzanne E Lapi; Mohammad Athar; Victor J Thannickal; A Brent Carter; Veena B Antony
Journal:  Sci Transl Med       Date:  2021-03-17       Impact factor: 17.956

6.  Mechanisms of Environment-Induced Autoimmunity.

Authors:  K Michael Pollard; David M Cauvi; Jessica M Mayeux; Christopher B Toomey; Amy K Peiss; Per Hultman; Dwight H Kono
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-28       Impact factor: 13.820

7.  Silicon, a Possible Link between Environmental Exposure and Autoimmune Diseases: The Case of Rheumatoid Arthritis.

Authors:  Cesar A Speck-Hernandez; Gladis Montoya-Ortiz
Journal:  Arthritis       Date:  2012-10-18

8.  The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity.

Authors:  Paul M Gallo; Stefania Gallucci
Journal:  Front Immunol       Date:  2013-06-10       Impact factor: 7.561

9.  Magnetic core-shell nanoparticles for drug delivery by nebulization.

Authors:  Navin Kumar Verma; Kieran Crosbie-Staunton; Amro Satti; Shane Gallagher; Katie B Ryan; Timothy Doody; Colm McAtamney; Ronan MacLoughlin; Paul Galvin; Conor S Burke; Yuri Volkov; Yurii K Gun'ko
Journal:  J Nanobiotechnology       Date:  2013-01-23       Impact factor: 10.435

10.  Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.

Authors:  Alexandros Laios; Bashir M Mohamed; Lynn Kelly; Richard Flavin; Stephen Finn; Lynda McEvoy; Michael Gallagher; Cara Martin; Orla Sheils; Martina Ring; Anthony Davies; Margaret Lawson; Noreen Gleeson; Tom D'Arcy; Charles d'Adhemar; Lucy Norris; Ream Langhe; Feras Abu Saadeh; John J O'Leary; Sharon A O'Toole
Journal:  Int J Mol Sci       Date:  2013-01-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.